Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marco Nuno De Canha has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Quantifying the roles of environmental, seasonal, and genome size variation in the expression of medicinally valuable compounds in Helichrysum kraussii Sch. Bip

    by Willem Hendrik Boshoff, Danielle Twilley, Marco Nuno De Canha, Namrita Lall, Kenneth Oberlander

  • Open Access

    Gunnera perpensa L. - mediated gold nanoparticles with enhanced anti-gonococcal activity

    by Tanyaradzwa Tiandra Dembetembe, Danielle Twilley, Jacqueline Maphutha, Marco Nuno De Canha, Velaphi Clement Thipe, Vusani Mandiwana, Michel Lonji Kalombo, Rirhandzu Rikhotso, Suprakas Sinha Ray, Namrita Lall, et al.


  • Open Access

    DNA barcoding and anti-tyrosinase activities of three species-representative populations of the genus Greyia Hook & Harv

    by Iné Botha, Marco N. De Canha, Kenneth Oberlander, Jana Botes, Namrita Lall, Dave K. Berger


  • Open Access

    Extracts of southern African aquatic and wetland plant species as effective tyrosinase inhibitors

    by Namrita Lall, Karina Mariam Szuman, Bonani Madikizela, Anna-Mari Kok, Marco Nuno De Canha


  • Open Access

    The potential of traditional medicinal plants against targets associated with Covid-19

    by Brandon Alston, Anna-Mari Kok, Marco Nuno De Canha, Namrita Lall

  • Open Access

    Assessing Anti-Inflammatory Activities and Compounds in Switchgrass (Panicum virgatum)

    by Khanh-Van Ho, Novianus Efrat, Kathy L. Schreiber, Phuc H. Vo, Marco N. De Canha, Analike Blom van Staden, Bianca D. Payne, Carel B. Oosthuizen, Danielle Twilley, Zhentian Lei, et al.

    Switchgrass is a bioenergy feedstock that potentially possesses multiple health benefits. However, the biological properties and associated bioactive compounds of switchgrass have not been adequately investigated. In the current study, we assessed the anti-inflammatory properties of switchgrass. Results from in vitro bioassays indicated that the methanolic extracts of switchgrass contained compounds exerting inhibitory effects on the expression of inflammatory mediators (TNF-α, IL-6, IL-8, and IL-10) induced in the U-937 model system. The extracts derived from four switchgrass cultivars (Alamo, Kanlow, Liberty, and Show Me) inhibited the secretion of all inflammatory mediators examined, with the only exception of the Liberty extract, which showed no significant effect on IL-10 expression. The degree of cytokine inhibition was variable, depending on the particular cultivar, the concentrations tested, and the cytokines examined. A global metabolomics approach was utilized to putatively identify possible molecules with known anti-inflammatory capacities in different switchgrass cultivars using ultra-high performance liquid chromatography with high-resolution mass spectrometry (UHPLC-HRMS). The content of multiple bioactive anti-inflammatory compounds in switchgrass was determined by liquid chromatography–tandem mass spectrometry (HPLC–MS/MS) analyses. Our results suggest that switchgrass, particularly the Alamo and Kanlow cultivars, may represent a promising natural anti-inflammatory source for the cosmetic, nutraceutical, and pharmaceutical industries.


  • Open Access

    Traditional Uses, Phytochemistry, and Pharmacology of Elegia Species: A Review

    by Panagiotis Lymperis, Ekaterina-Michaela Tomou, Marco Nuno De Canha, Namrita Lall, Helen Skaltsa

    In South Africa, plants belonging to the Restionaceae family possess an ecological dominance. As a result, they have been the subject of numerous morphological, anatomical, and evolutionary studies. However, few studies have focused on their phytochemical profile and their potential pharmacological activities. The genus Elegia L. is the second largest of this family comprising 52 species, which are mainly used as materials for thatching. Limited studies on the chemical constituents of Elegia species and their importance as medicinal plants have been undertaken. This review provides constructive and extensive information about the botanical characterization, distribution, traditional uses, phytochemistry and pharmacology of the genus Elegia. A comprehensive search of previously published literature was performed for studies on this genus, using databases with different key search words. This survey documented 52 Elegia species summarizing their previous taxonomic classification. In addition, 14 species were found to be studied for their phytochemical profile, revealing 14 chemical compounds. Concerning their biological activities, only one species (E. tectorum (L.f.) Moline and H.P.Linder) is reported for its anti-wrinkle activity. Moreover, two species are locally used for thatching and as materials for brooms. The present review highlights the Elegia genus as an important source of bioactive phytochemicals with flavonol glycosides being the main metabolites and reveals the uncharted territory of this genus for new research studies.


  • Open Access

    Sideritis Perfoliata (Subsp. Perfoliata) Nutritive Value and Its Potential Medicinal Properties

    by Namrita Lall, Antonios Chrysargyris, Isa Lambrechts, Bianca Fibrich, Analike Blom Van Staden, Danielle Twilley, Marco Nuno de Canha, Carel Basson Oosthuizen, Dikonketso Bodiba, Nikolaos Tzortzakis

    Sideritis perfoliata L. subsp. perfoliata is an endemic species of the Eastern Mediterranean region with several uses in traditional medicine. The present study aims to explore the unknown properties of S. perfoliata investigating the nutritional content as well as the antioxidant, anticancer, antituberculosis, antiwrinkle, anti-acne, hyper/hypo-pigmentation and antibacterial activities. Mineral content, nutritional value, the composition and antioxidant properties of the essential oil, the antityrosinase, the antibacterial activity and anti-elastase potential of the extract, were evaluated. The antiproliferative activity of S. perfoliata against cervical cancer (HeLa), human melanoma (UCT-Mel-1), human hepatocellular carcinoma (HepG2) and human epidermoid carcinoma (A431) was investigated. Cytotoxic effects on normal human keratinocyte (HaCat) and kidney epithelial (Vero) cell lines were also determined. Sideritis perfoliata exhibited high nutritional value of proteins and minerals (K, P, Mg, Fe, Zn, Cu). The most abundant components of the essential oil were found to be α-pinene, β-phelladrene, valeranone, β-pinene and sabinene. The ethanolic extract of S. perfoliata displayed moderate antioxidant potential and antibacterial activity against Prevotella intermedia. Noteworthy elastase and moderate anticancer potential against the human liver cancer cell line (HepG2) was observed with IC50 values of 57.18 ± 3.22 μg/mL and 64.27 ± 2.04 μg/mL respectively. The noteworthy in vitro activity of S. perfoliata could be due to the presence of flavonoids and phenols in the leaves, having high nutritional value. Sideritis perfoliata could potentially be useful to reduce the appearance of wrinkles and for the treatment of liver cancer. The moderate antibacterial, antioxidant and elastase activity of the plant can be linked to the traditional use of S. perfoliata for the treatment of wounds and inflammation.